Status:
COMPLETED
A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Lead Sponsor:
Daiichi Sankyo Co., Ltd.
Conditions:
Prevention
Venous Thromboembolism
Eligibility:
All Genders
20-84 years
Phase:
PHASE3
Brief Summary
The objective of this study is to assess the efficacy and safety of DU-176b compared with enoxaparin sodium for the prevention of venous thromboembolism in patients after elective total hip arthroplas...
Eligibility Criteria
Inclusion
- Patients undergoing unilateral total hip arthroplasty
Exclusion
- Subjects with risks of hemorrhage
- Subjects with thromboembolic risks
- Subjects who weigh less than 40 kg
- Subjects who are pregnant or suspect pregnancy, or subjects who want to become pregnant
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
610 Patients enrolled
Trial Details
Trial ID
NCT01181167
Start Date
May 1 2009
End Date
March 1 2010
Last Update
March 5 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Osaka, Japan
2
Tokyo, Japan